Navigation Links
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
Date:4/22/2009

ted method of composition and has fewer side effects. Lotus plans to launch the drug by 2012, pending on the approval from SFDA. Class I drug in China means that it is a breakthrough invention in China and there is no similar drug elsewhere outside of China. Currently the Company believes 30-50 million patients in China suffer from asthma.

About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )

Lotus Pharmaceuticals, Inc. controls and operates Liang Fang Pharmaceutical, Ltd. ("Liang Fang") and Enze Jiashi Pharmaceutical, Ltd. ("Enze"), two pharmaceutical companies located in Beijing, China. Together, Liang Fang and Enze ("Lotus East") undertake the development, production, marketing and distribution of pharmaceutical products. The Company believes Lotus East has some of the most advanced pharmaceutical production equipment in China and its manufacturing facilities meet national Good Manufacturing Practices. The Company distributes its own portfolio of drugs and pharmaceutical products produced by other manufacturers in the PRC through an extensive national distribution network. Lotus owns ten pharmacies in Beijing through which it directly sells over 5,000 western drugs, Traditional Chinese Medicines and medical equipment items.

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including, but not limited to, changes from anticipated levels of sales, future national or regional economic and competitive and regulatory conditions, changes in rel
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
3. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...NFRANCISCO,Nov.25/PRNewswire/--IntroducingPariBeau...smeticsandadvancedskincarededicatedtoprovidingpres...isthefirstprestigeskincareandcolorcosmeticbrandtol...tores,withofficesinSanFranciscoandToronto,wasfound...essionalswithover35yearsexperienceintheindustry.Pa...
(Date:11/25/2009)... Dentistry is evolving beyond the t...overs. In fact, it is looking at these more tradit...eservation and beauty of teeth is what the public ...now, more than ever, an important part of the medi...oral and systemic health is being strengthened eve...
(Date:11/25/2009)... Dr. Neil J. Zemmel, a board-certif...new website utilizing the latest internet technolo...reast reconstruction procedures. The new site inco... interactive web experience that’s designed ...r of Dr. Zemmel’s practice. , ...
(Date:11/25/2009)... Partners Consulting again commits ...ance. , (PRWEB) November ...ounced that their Data Center operation has comple...ountants’ Statement on Auditing Standards (S...ally recognized audit for validating the internal ...
(Date:11/25/2009)... The American Society of Hematology... publishing, education, and media company, are lau... a dynamic science curriculum designed to spark in...ddition to exposing students to exciting career op... Washington (PRWEB) November 25, 2009 -- The Am...
Breaking Medicine News(10 mins):Health News:Pari Beauty Professional Artistry 2Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 2Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 4Health News:Partners Consulting Completes SAS70 Audit 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3
... Aug. 4 U.S. Preventive Medicine, the leader in,d...pleted its participation,in a major pilot project ...(NCQA) to evaluate The Prevention Plan(TM), its gr... the agreement, U.S. Preventive Medicine is one of...
...ORO, N.C., Aug. 4 Medical Justice Services,Inc., ...sts defend,themselves against meritless medical ma...roduced a new way for physicians and dentists to f...nd blogs, solves a problem that,s exploded in the,...
...SBURGH, Aug. 4 Antiretroviral drugs for HIV do no...a central risk factor for heart disease, according...aduate School of Public Health to be published in ... protection against atherosclerosis hardening of ...
... In the white paper, "All ...tes Senior Consultant Jay Gordon Cone provides a m...s leaders assess if their teams are high-performin...environments. Yet in many companies, http://www.i...
... A paper published in the Inter...the Fudan-Cinpathogen Clinical and Molecular Resea...aboration with the University of Colorado, and Cin...iagnosis and classification were performed by a si...
...vals consistent with current US treatment guidelin...mbination therapies, - Up to 80% of patients may ... blood pressure goals, - Singl...e approvals may benefit patients who are likely to...
Other Medicine News:Health News:National Committee for Quality Assurance Selects U.S. Preventive Medicine for Health Promotion Pilot Project 2Health News:Medical Justice Services Inc. Now Offers Online Anti-Defamation Service 2Health News:Medical Justice Services Inc. Now Offers Online Anti-Defamation Service 3Health News:Long-term HIV treatment may reduce risk for atherosclerosis 2Health News:New White Paper by Performance Improvement Innovator Interaction Associates Helps Business Leaders Assess Team Effectiveness 2Health News:Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 3Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 4Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 5Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 6Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 7
(Date:11/25/2009)... ,, BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Re...elopmentofantithromboticaptamerswithactivecontrola...willbepresentingatthePiperJaffray21stAnnualHealthC...Dr.Mazzo,spresentationwillbegivenat1:10pm(EST)onTu...y,spipelinewithemphasisontheleaddevelopmentprogram...
(Date:11/25/2009)... ,, UNIONCITY,Calif.,Nov.25/PRNewswire-First...companymanufacturingpoint-of-carebloodanalysissyst...efexecutiveofficer,willpresentatthe21stAnnualPiper...009at2:00p.m.ET.TheconferencewillbeheldattheNewYor..., Abaxisdevelops,manufacturesandmarketsportablebl...
(Date:11/25/2009)... ,, CHAPELHILL,N.C.,Nov.25/PRNewswire/--Cemp...Fernandes,presidentandchiefexecutiveofficer,willpr...ceat8:50a.m.EST,December1,2009,atTheNewYorkPalaceH...wofthecompany,stwoleadingantibioticclinicalprogram...MRSA. ,, AboutCempraPharmaceuticals ,, Fou...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 1Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 2Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 3Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 4Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson 50143 1Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson 50143 2Latin America must cut blood pressure to thrive 50141 1Latin America must cut blood pressure to thrive 50141 2Latin America must cut blood pressure to thrive 50141 3
...ovement in disease activity observed through 2.5 y...continuation trial -, - No observed increase in ra...alignancies and infections over 2.5 years of Lymph...n Genome Sciences,Inc. (Nasdaq: HGSI ) today anno... demonstrating that LymphoStat-B(R) (belimumab) ac...
...expanded routine screening, WASHINGTON, Nov. 8 T...ommission for Public Health and the North,Carolina...ws to include the,Centers for Disease Control and ...ning a part of routine medical care. Now in North ...ral consent and pre-test counseling is,no longer r...
Other Medicine Technology:Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 8Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing 2
5107 Bariatric Physician's Scale®
...100 provides a new screening, diagnostic, treatmen...n the medical management of sleep-related breathin...ill the unmet need for an ambulatory, reliable, pa...accessible to the great number of OSA sufferers, a...
...rmone (PTH) is synthesized by the parathyroid glan...racellular calcium concentrations. PTH prevents hy...sing calcium excretion by the kidney. Following re...degraded into 4 fragments: N-terminal (residues 1-...
...osterone (DHEA) is produced in the adrenal cortex ...serves as a precursor in testosterone and estrogen...ivity, estimated at ~10% that of testosterone [1]....n adult women, DHEA is an important androgen as ci...
Medicine Products: